Skip to main content

Table 2 Summary of results for analysis of associations between VDR variants and melanoma risk (total and stratified analysis)

From: Variants Fok1 and Bsm1 on VDR are associated with the melanoma risk: evidence from the published epidemiological studies

Variant

Genetic model

Total

PCC

HCC

OR (95% CI)

Q/df

P a

I 2

OR (95% CI)

Q/df

P a

I 2

OR (95% CI)

Q/df

P a

I 2

Bsm1

Bb vs. bb

0.85 (0.76-0.95)

2.46/5

0.782

0%

0.90 (0.78-1.04)

0.44/3

0.933

0%

0.75 (0.60-0.92)

NA

NA

NA

 

BB vs. bb

0.83 (0.68-1.00)

6.92/5

0.227

28%

0.81 (0.59-1.13)

6.55/3

0.088

54%

0.78 (0.59-1.04)

NA

NA

NA

 

BB + Bb vs. bb

0.85 (0.76-0.94)

3.79/5

0.580

0%

0.89 (0.78-1.02)

1.98/3

0.577

0%

0.75 (0.62-0.92)

NA

NA

NA

Cdx2

GA vs. GG

0.95 (0.81-1.13)

0.49/2

0.784

0%

0.92 (0.76-1.12)

0.03/1

0.867

0%

NA

NA

NA

NA

 

AA vs.GG

1.00 (0.68-1.46)

1.71/2

0.426

0%

1.10 (0.73-1.67)

0.20/1

0.656

0%

NA

NA

NA

NA

 

AA + GA vs. GG

0.96 (0.82-1.12)

0.15/2

0.929

0%

0.96 (0.79-1.14)

0.07/1

0.786

0%

NA

NA

NA

NA

EcoRV

GA vs. AA

1.09 (0.93-1.27)

11. 4/7

0.122

39%

1.12 (0.93-1.36)

9.66/5

0.085

48%

1.00 (0.70-1.41)

1.36/1

0.244

26%

 

GG vs. AA

1.09 (0.90-1.33)

10.32/7

0.182

32%

1.00 (0.85-1.18)

4.99/5

0.417

0%

1.63 (0.79-3.36)

2.58/1

0.108

61%

 

GA + GG vs. AA

1.09 (0.94-1.26)

10.91/7

0.143

36%

1.09 (0.92-1.29)

8.70/5

0.122

43%

1.15 (0.74-1.78)

2.19/1

0.139

54%

Fok1

Ff vs. FF

1.18 (1.06-1.30)

5.65/8

0.686

0%

1.14 (0.99-1.31)

2.21/4

0.697

0%

1.27 (1.08-1.49)

1.62/2

0.444

0%

 

ff vs. FF

1.19 (1.01-1.41)

10.25/8

0.248

22%

1.20 (0.92-1.58)

7.05/4

0.133

43%

1.12 (0.85-1.49)

2.39/2

0.303

16%

 

ff + Ff vs. FF

1.18 (1.07-1.29)

7.21/8

0.515

0%

1.15 (1.01-1.31)

3.98/4

0.409

0%

1.24 (1.04-1.49)

2.5/2

0.287

20%

Taq1

Tt vs. TT

1.03 (0.83-1.27)

20.47/6

0.002

71%

1.11 (0.86-1.42)

8.06/3

0.045

63%

0.92 (0.64-1.34)

7.66/2

0.022

74%

 

tt vs. TT

0.97 (0.75-1.27)

16.07/6

0.013

63%

1.11 (0.78-1.57)

7.98/3

0.046

62%

0.79 (0.57-1.11)

3.26/2

0.196

39%

 

tt + Tt vs. TT

1.03 (0.82-1.28)

24.76/6

< 0.001

76%

1.12 (0.86-1.46)

10.20/3

0.017

71%

0.91 (0.63-1.31)

8.23/2

0.016

76%

Apa1

Aa vs. AA

1.14 (0.94-1.39)

0.46/2

0.795

0%

1.14 (0.94-1.39)

0.46/2

0.795

0%

NA

NA

NA

NA

 

aa vs. AA

1.07 (0.75-1.54)

3.96/2

0.138

50%

1.07 (0.75-1.54)

3.96/2

0.138

50%

NA

NA

NA

NA

 

aa + Aa vs. AA

1.12 (0.93-1.34)

1.68/2

0.431

0%

1.12 (0.93-1.34)

1.68/2

0.431

0%

NA

NA

NA

NA

  1. aP for heterogeneity test.
  2. Abbreviations: OR odds ratio; 95% CI 95% confidence interval, PCC population-based case–control, HCC hospital-based case–control, NA not applicable.